Jin Shan, Liu Min-Da, Wu Hong, Pang Pai, Wang Song, Li Zhen-Ning, Sun Chang-Fu, Liu Fa-Yu
Department of Oromaxillofacial-Head and Neck Surgery, Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, Shenyang, Liaoning 110002, P.R. China.
Department of Stomatology, The 4th Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China.
Oncol Lett. 2018 Jun;15(6):9703-9710. doi: 10.3892/ol.2018.8564. Epub 2018 Apr 25.
Head and neck squamous cell carcinoma (HNSCC) is usually diagnosed accompanied by lymph node metastasis. C-C chemokine receptor type 7 (CCR7) is associated with the invasion and metastasis of tumors in HNSCC through various signaling pathways. The role of hsa-miR-125a-5p in HNSCC remains unclear. The present study was performed to investigate the association between hsa-miR-125a-5p and CCR7 in HNSCC. Reverse transcription-quantitative polymerase chain reaction was applied to analyze the expression of hsa-miR-125a-5p in clinical samples. Cell Counting Kit-8, Transwell and wound healing assays were used to detect cell proliferation, invasion, and metastasis, respectively, following overexpression of hsa-miR-125a-5p. Changes in protein expression of CCR7 were observed using western blotting. In the survival analysis, Student's t-tests and log rank tests were performed to analyze the association between the expression of hsa-miR-125a-5p, and HNSCC according to the Cancer Genome Atlas database. The expression of hsa-miR-125a-5p was identified to be significantly lower in cancer tissue compared with the corresponding adjacent normal tissues in clinical samples (P=0.038). The results of western blotting indicated that there was a positive regulatory association between hsa-miR-125a-5p and CCR7. Furthermore, overexpression of hsa-miR-125a-5p significantly enhanced the ability of cell proliferation, migration and invasion in HNSCC, with upregulation of CCR7. The results of survival analysis revealed that patients in the low expression group of hsa-miR-125a-5p tended to have longer survival times compared with the high expression group (P=0.045). Altogether, the data raised the possibility that hsa-miR-125a-5p has a significant role in promoting cancer in HNSCC, which may provide a basis for the treatment of HNSCC in molecular targeted therapy. Further studies are required to ascertain the role of hsa-miR-125a-5p in other HNSCC cell lines and .
头颈部鳞状细胞癌(HNSCC)通常在诊断时伴有淋巴结转移。C-C趋化因子受体7型(CCR7)通过多种信号通路与HNSCC肿瘤的侵袭和转移相关。hsa-miR-125a-5p在HNSCC中的作用尚不清楚。本研究旨在探讨hsa-miR-125a-5p与HNSCC中CCR7之间的关联。应用逆转录-定量聚合酶链反应分析临床样本中hsa-miR-125a-5p的表达。在hsa-miR-125a-5p过表达后,分别使用细胞计数试剂盒-8、Transwell和伤口愈合试验检测细胞增殖、侵袭和转移情况。使用蛋白质印迹法观察CCR7蛋白表达的变化。在生存分析中,根据癌症基因组图谱数据库,采用学生t检验和对数秩检验分析hsa-miR-125a-5p表达与HNSCC之间的关联。在临床样本中,与相应的癌旁正常组织相比,癌组织中hsa-miR-125a-5p的表达显著降低(P = 0.038)。蛋白质印迹结果表明hsa-miR-125a-5p与CCR7之间存在正调控关联。此外,hsa-miR-125a-5p的过表达显著增强了HNSCC细胞的增殖、迁移和侵袭能力,同时CCR7表达上调。生存分析结果显示,与高表达组相比,hsa-miR-125a-5p低表达组患者的生存时间往往更长(P = 0.045)。总之,这些数据提示hsa-miR-125a-5p在促进HNSCC肿瘤发生中具有重要作用,这可能为分子靶向治疗HNSCC提供依据。需要进一步研究以确定hsa-miR-125a-5p在其他HNSCC细胞系中的作用以及……